Intellia Therapeutics

Intellia Therapeutics is a biotechnology company based in Cambridge, United States. It was founded in 2014, and its shares are listed on the Nasdaq. Its registered legal name is INTELLIA THERAPEUTICS, INC.

Facts as of Nov 19, 2026.

Facts

FactValueSource
Legal nameINTELLIA THERAPEUTICS, INC.GLEIF (opens in a new tab)
Websiteintelliatx.com (opens in a new tab)Wikidata (opens in a new tab)
HeadquartersCambridge, United StatesWikidata (opens in a new tab)
Founded2014Wikidata (opens in a new tab)
ListedListedSEC EDGAR (opens in a new tab)
Stock exchangesNasdaqWikidata (opens in a new tab)
IndustryBiotech and pharma, BiotechnologyWikidata (opens in a new tab)
SEC industry code2835 In Vitro & In Vivo Diagnostic SubstancesSEC EDGAR (opens in a new tab)
LEI5493002T5BCPE5DZC723GLEIF (opens in a new tab)
SEC CIK1652130SEC EDGAR (opens in a new tab)
WikidataQ54621387Wikidata (opens in a new tab)

Each fact links to the record it came from. The company website is the only contact on this page.

Appears in

Similar companies

Sources

The description is written by Openlead from these facts.